WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Options
Query Language
Stem
Sort by:
List Length
Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018060688) ANTIGEN BIOMARKERS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/060688 International Application No.: PCT/GB2017/052879
Publication Date: 05.04.2018 International Filing Date: 27.09.2017
IPC:
G01N 33/574 (2006.01) ,A61K 38/00 (2006.01)
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33
Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48
Biological material, e.g. blood, urine; Haemocytometers
50
Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53
Immunoassay; Biospecific binding assay; Materials therefor
574
for cancer
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
Applicants: THE UNIVERSITY OF THE HIGHLANDS AND ISLANDS[GB/GB]; Executive Office 12b Ness Walk Inverness IV3 5SQ, GB
Inventors: WEI, Jun; GB
Agent: HGF LIMITED (GLASGOW); 1 City Walk Leeds Yorkshire LS11 9DX, GB
Priority Data:
1616357.827.09.2016GB
1705988.213.04.2017GB
Title (EN) ANTIGEN BIOMARKERS
(FR) BIOMARQUEURS ANTIGÉNIQUES
Abstract:
(EN) Peptide antigens are provided that may be used to screen blood plasma for antibodies that be used as anticancer therapeutics. Kits comprising the peptide antigens, and methods of using the same are also provided.
(FR) La présente invention concerne des antigènes peptidiques qui peuvent être utilisés pour cribler du plasma sanguin pour des anticorps qui peuvent être utilisés en tant qu’agents thérapeutiques anticancéreux. L’invention concerne en outre des kits comprenant les antigènes peptidiques, et des procédés d’utilisation de ceux-ci.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)